Vincerx Pharma Inc. (VINC) NASDAQ

$5.06 (1) (-16.50%)

Market Cap: $129.57M

As of 03/28/24 04:00 PM EDT. Market closed.

(VINC)

Vincerx Pharma Inc. (VINC)
NASDAQ

$5.06
(1) (-16.50%)

Market Cap: $129.57M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

vincerx is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of ... read more

vincerx is a clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
7
Address
.
PRICE CHART FOR VINCERX PHARMA INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.76
Previous Close
$6.06
Days Range
$5.13 - $6.10
52 week range
$0.61 - $9.37
Volume
605,406
Avg. Volume (30 days)
820,673
Market Cap
$129.57M
Dividend Yield
-
P/E
-
Shares Outstanding
21,380,570
Open
$5.76
Previous Close
$6.06
Days Range
$5.13 - $6.10
52 week range
$0.61 - $9.37
Volume
605,406
Avg. Volume (30 days)
820,673
Market Cap
$129.57M
Dividend Yield
-
P/E
-
Shares Outstanding
21,380,570
FINANCIAL STATEMENTS FOR VINCERX PHARMA INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR VINCERX PHARMA INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Seelenberger Alexander A.See RemarksAug 11, 2023 Buy$0.9510,5009,96830,280Aug 14, 2023, 04:09 PM
Hamdy Ahmed MDSee RemarksAug 10, 2023 Buy$0.965,4005,16796,060Aug 10, 2023, 06:28 PM
Hamdy Ahmed MDSee RemarksAug 09, 2023 Buy$0.9516,90015,99490,660Aug 10, 2023, 06:28 PM
THOMAS TOM CSee RemarksAug 10, 2023 Buy$0.955,0004,750219,935Aug 10, 2023, 06:28 PM
Izumi Raquel E.See RemarksAug 10, 2023 Buy$0.933,4403,19985,214Aug 10, 2023, 06:27 PM
Izumi Raquel E.See RemarksAug 09, 2023 Buy$0.9013,03611,73581,774Aug 10, 2023, 06:27 PM
Izumi Raquel E.See RemarksDec 14, 2022 Buy$0.8828,73825,42768,738Dec 14, 2022, 09:22 PM
Hamdy Ahmed MDChief Executive OfficerDec 14, 2022 Buy$0.8735,28030,53873,760Dec 14, 2022, 09:22 PM
THOMAS TOM CSee RemarksDec 14, 2022 Buy$0.837,0005,81010,000Dec 14, 2022, 09:22 PM
LOWE CHRISTOPHER P.DirectorAug 25, 2022 Buy$1.6511,60019,13940,000Aug 26, 2022, 04:06 PM
LOWE CHRISTOPHER P.DirectorAug 24, 2022 Buy$1.6518,40030,29928,400Aug 26, 2022, 04:06 PM
Izumi Raquel E.See RemarksJun 27, 2022 Buy$1.4140,00056,31240,000Jun 29, 2022, 04:05 PM
Hamdy Ahmed MDChief Executive OfficerJun 23, 2022 Buy$1.4124,20034,13738,480Jun 27, 2022, 07:20 PM
Bushnell Laura I.DirectorJun 09, 2022 Buy$1.9115,00028,62519,202Jun 13, 2022, 08:01 PM
THOMAS TOM CSee RemarksDec 22, 2021 Buy$10.231,00010,2303,000Dec 27, 2021, 04:48 PM
Hwang SooinChief Business OfficerDec 23, 2021 Buy$10.003,00030,000390,491Dec 27, 2021, 04:42 PM
Bushnell Laura I.DirectorDec 22, 2021 Buy$10.482,40225,1734,202Dec 27, 2021, 04:39 PM
Seelenberger Alexander A.Chief Financial OfficerDec 22, 2021 Buy$10.342,41724,98812,493Dec 27, 2021, 04:34 PM
Hamdy Ahmed MDChief Executive OfficerDec 22, 2021 Buy$10.026,45064,65014,280Dec 27, 2021, 04:28 PM
Izumi Raquel E.See RemarksAug 04, 2021 Buy$11.961,00011,9601,000Aug 06, 2021, 04:45 PM
Lee John H.DirectorJun 29, 2021 Buy$12.7279910,159799Jul 01, 2021, 06:52 PM
McDonald Andrew IDirectorJun 29, 2021 Buy$12.3820,000247,60020,000Jul 01, 2021, 06:05 AM
Hamdy Ahmed MDChief Executive OfficerJun 29, 2021 Buy$12.777,83099,9897,830Jun 30, 2021, 07:02 PM
Bushnell Laura I.DirectorJun 30, 2021 Buy$12.941,80023,2971,800Jun 30, 2021, 07:02 PM
Seelenberger Alexander A.Chief Financial OfficerJun 29, 2021 Buy$12.617,950100,2607,950Jun 30, 2021, 06:59 PM
LOWE CHRISTOPHER P.DirectorJun 29, 2021 Buy$12.596,40080,5766,400Jun 30, 2021, 06:59 PM
LOWE CHRISTOPHER P.DirectorJun 30, 2021 Buy$12.663,60045,57610,000Jun 30, 2021, 06:59 PM
THOMAS TOM CSee RemarksJun 29, 2021 Buy$12.582,00025,1602,000Jun 30, 2021, 06:57 PM
Hwang SooinChief Business OfficerJun 30, 2021 Buy$12.665006,330385,575Jun 30, 2021, 06:56 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Seelenberger Alexander A.See Remarks08/11/20239,968
Hamdy Ahmed MDSee Remarks08/10/20235,167
Hamdy Ahmed MDSee Remarks08/09/202315,994
THOMAS TOM CSee Remarks08/10/20234,750
Izumi Raquel E.See Remarks08/10/20233,199
Izumi Raquel E.See Remarks08/09/202311,735
Izumi Raquel E.See Remarks12/14/202225,427
Hamdy Ahmed MDChief Executive Officer12/14/202230,538
THOMAS TOM CSee Remarks12/14/20225,810
LOWE CHRISTOPHER P.Director08/25/202219,139
LOWE CHRISTOPHER P.Director08/24/202230,299
Izumi Raquel E.See Remarks06/27/202256,312
Hamdy Ahmed MDChief Executive Officer06/23/202234,137
Bushnell Laura I.Director06/09/202228,625
THOMAS TOM CSee Remarks12/22/202110,230
Hwang SooinChief Business Officer12/23/202130,000
Bushnell Laura I.Director12/22/202125,173
Seelenberger Alexander A.Chief Financial Officer12/22/202124,988
Hamdy Ahmed MDChief Executive Officer12/22/202164,650
Izumi Raquel E.See Remarks08/04/202111,960
Lee John H.Director06/29/202110,159
McDonald Andrew IDirector06/29/2021247,600
Hamdy Ahmed MDChief Executive Officer06/29/202199,989
Bushnell Laura I.Director06/30/202123,297
Seelenberger Alexander A.Chief Financial Officer06/29/2021100,260
LOWE CHRISTOPHER P.Director06/29/202180,576
LOWE CHRISTOPHER P.Director06/30/202145,576
THOMAS TOM CSee Remarks06/29/202125,160
Hwang SooinChief Business Officer06/30/20216,330
Load More Insider Transactions
FUNDS WITH A POSITION IN VINCERX PHARMA INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
RENAISSANCE TECHNOLOGIES LLC176,0200.00032%32.45%Other
GEODE CAPITAL MANAGEMENT, LLC154,0310.00002%No changeOther
BLACKROCK INC.64,2590%No changeOther
CHANGE IN SHARES OUTSTANDING FOR VINCERX PHARMA INC
STOCK BUYBACKS FOR VINCERX PHARMA INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
0.33%
1Q
09/30/2023
03/31/2023
0.74%
2Q
09/30/2023
12/31/2022
0.97%
3Q
09/30/2023
09/30/2022
1.24%
4Q
09/30/2023
06/30/2022
1.67%
5Q
09/30/2023
03/31/2022
2.15%
6Q
09/30/2023
12/31/2021
24.27%
7Q
09/30/2023
09/30/2021
20.63%
8Q
09/30/2023
06/30/2021
30.55%
9Q
09/30/2023
03/31/2021
55.41%
10Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
0.33%
1Q
03/31/2023
0.74%
2Q
12/31/2022
0.97%
3Q
09/30/2022
1.24%
4Q
06/30/2022
1.67%
5Q
03/31/2022
2.15%
6Q
12/31/2021
24.27%
7Q
09/30/2021
20.63%
8Q
06/30/2021
30.55%
9Q
03/31/2021
55.41%
10Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR VINCERX PHARMA INC
LOADING...